TARAMASSO, LUCIA
 Distribuzione geografica
Continente #
EU - Europa 7.613
Totale 7.613
Nazione #
IT - Italia 7.613
Totale 7.613
Città #
Genova 5.419
Rapallo 1.278
Genoa 872
Bordighera 44
Totale 7.613
Nome #
Management of ventilator-associated pneumonia: epidemiology, diagnosis and antimicrobial therapy 240
CD8+CD28-CD127loCD39+regulatory T-cell expansion: A new possible pathogenic mechanism for HIV infection? 172
Is it still worthwhile to perform quarterly CD4+ T lymphocyte cell counts on HIV-1 infected stable patients? 163
Epidemiological and clinical features of hepatitis delta in HBsAg-positive patients by HIV status. 153
Case report: management and HBV sequencing in a patient co-infected with HBV and HIV failing tenofovir. 148
Pharmacokinetics of Lopinavir Determined with an ELISA Test in Youths with Perinatally Acquired HIV. 140
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 132
Effectiveness of a project to prevent HIV vertical transmission in the Republic of Congo. 131
Bloodstream infections in patients living with HIV in the modern cART era 129
Pregnancy and neonatal outcomes among a cohort of HIV-infected women in a large Italian teaching hospital: a 30-year retrospective study 128
Will new antimicrobials overcome resistance among Gram-negatives? 118
Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy. 115
Which patients have greatest need for elvitegravir/cobicistat/ emtricitabine/tenofovirDF-based therapy? 111
Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir ± ribavirin in HIV/HCV co-infected patients 110
Chemotherapy Mass Campaigns and Migratory Flows: An Unexpected Connection 109
Role of [18F]Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography for Diagnosis and Treatment of Sarcoidosis in an HIV-2-Infected Patient. 106
Successful recovery of associated interstitial nephritis and focal segmental glomerulosclerosis in patients with HCV and HIV treated with sofosbuvir and daclatasvir and revision of literature 105
Reducing CD4+ lymphocyte cell monitoring in HIV-1 stable patients: a forecast of the cost saving 103
Bedaquiline: A new hope for shorter and better anti-tuberculosis regimens 100
Successful antiretroviral therapy by using unusual antiretroviral combinations in heavily pre-treated patients: two case reports 99
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: Results from a large observational cohort study (SCOLTA) 98
Increasing prevalence of genitourinary schistosomiasis in Europe in the Migrant Era: Neglected no more? 96
Successful antiretroviral therapy by using unusual antiretroviral combinations in heavily pre-treated patients: two case reports 94
Time to change the single-centre approach to management of patients with tuberculosis: a novel network platform with automatic data import and data sharing 94
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 93
How has the cost of antiretroviral therapy changed over the years? A database analysis in Italy 93
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort 92
AUMENTO DEGLI INDICI DI CITOLISI EPATICA NEI SOGGETTI CON INFEZIONE DA HIV CHE AVVIANO LA PRIMA LINEA DI TRATTAMENTO ANTIRETROVIRALE: STUDIO OSSERVAZIONALE DI COORTE 92
Patient-reported outcomes and low-level residual HIV-RNA in adolescents perinatally infected with HIV-1 after switching to one-pill fixed-dose regimen. 90
Rationale for an association between PD1 checkpoint inhibition and therapeutic vaccination against HIV 89
Pineal Germinoma in a Child with Interferon-γ Receptor 1 Deficiency. Case Report and Literature Review 89
How relevant is the HIV low level viremia and how is its management changing in the era of modern ART? A large cohort analysis 89
Switch from unboosted protease inhibitor to a single-tablet regimen containing rilpivirine improves cholesterol and triglycerides 87
Lipid profile changings after switching from rilpivirine/tenofovir disoproxil fumarate/ emtricitabine to rilpivirine/tenofovir alafenamide/emtricitabine: Different effects in patients with or without baseline hypercholesterolemia 83
Ibalizumab and fostemsavir in the management of heavily pre-treated HIV-infected patients 83
Onychomadesis in a male patient with secondary syphilis 82
Weight gain: A possible side effect of all antiretrovirals 82
Factors associated with hospital admission for COVID-19 in HIV patients 81
Treatment of hepatitis C virus genotype 4 in the DAA era 79
Bloodstream infections in critically ill patients with COVID-19 79
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 79
Short Communication: Tenofovir Disoproxil Fumarate/Emtricitabine Fits for All as Appropriate HIV-1 Pre-Exposure Prophylaxis? 78
Raltegravir-based therapy in a cohort of HIV/HCV co-infected individuals 78
Is it time to re-think the use of etravirine in patients with available genotypic resistance test? 78
Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study 78
HIV-1 RNA quantification in CRF02_AG HIV-1 infection: too easy to make mistakes 76
Hepatitis C virus direct acting antivirals impact on renal function in the first 4 weeks of treatment 76
Co-infezione HIV/HCV e malattia renale: un binomio “scindibile” 75
Will vaccine hesitancy compromise our efforts to face the next SARS-CoV-2 epidemic wave? 73
Control of the HIV-1 DNA reservoir is associated in vivo and in vitro with NKp46/NKp30 (CD335 CD337) inducibility and interferon gamma production by transcriptionally unique NK cells 72
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 72
Therapeutic management of chronic hepatitis B in clinical Practice: a region-wide survey. 71
Co-administration of tenofovir plus protease inhibitor based antiretroviral therapy during sofosbuvir/ledipasvir treatment for HCV infection: Much Ado About Nothing? 71
Treatment simplification to atazanavir/ritonavir+lamivudine versus maintenance of atazanavir/ritonavir+two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M) 70
HCV elimination plan leads to significant benefits in managing liver-related diseases and hospital interventions: a regional simulation 67
Prevalence of Antibodies to SARS-CoV-2 in Italian Adults and Associated Risk Factors 66
Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients 65
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study 64
Missed opportunities to prevent mother-to-child transmission of HIV in Italy 62
Bloodstream infections in patients living with HIV infection in the recent cART era: did something change?”. 62
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia 61
Lipid profile changings after switching from rilpivirine/tenofovir disoproxil fumarate/emtricitabine to rilpivirine/tenofovir alafenamide/emtricitabine: different effects in different patients populations. Results from a large observational study 60
Lipid profile improvement in virologically suppressed hiv-1-infected patients switched to dolutegravir/ abacavir/lamivudine: Data from the SCOLTA project 60
Computed tomography assessment of PEEP-induced alveolar recruitment in patients with severe COVID-19 pneumonia 60
Statins and Aspirin use in HIV-infected people: gap between European AIDS Clinical Society guidelines and clinical practice: the results from HIV-HY study 58
Maintenance of Viral Suppression after Optimization Therapy from Etravirine Plus Raltegravir to Rilpivirine Plus Dolutegravir in HIV-1-Infected Patients 57
Time trend in hypertension prevalence, awareness, treatment, and control in a contemporary cohort of HIV-infected patients: The HIVand Hypertension Study 57
Use of quantitative ultrasound as bone mineral density evaluation in an Italian female population living with HIV: A real-life experience 57
Ligurian Vaccination in HIV Program (LIV in HIV): the experience of Genoa metropolitan area 57
Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy 57
HCV elimination plan leads to significant benefits in managing liver-related diseases and hospital interventions: a regional simulation 56
Increasing use and accessibility of anti parasitic drugs for migrants with neglected diseases at a time of migratory emergency 55
Lung distribution of gas and blood volume in critically ill COVID-19 patients: a quantitative dual-energy computed tomography study 52
HCV elimination plan leads to significant benefits in managing liver-related diseases and hospital interventions: a regional simulation 51
null 51
Bloodstream infections in HIV-infected patients 47
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity 47
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 46
Spread of carbapenem-resistant gram-negatives and candida auris during the covid-19 pandemic in critically ill patients: One step back in antimicrobial stewardship? 44
Early effects of ventilatory rescue therapies on systemic and cerebral oxygenation in mechanically ventilated COVID-19 patients with acute respiratory distress syndrome: a prospective observational study 44
Immunological profile of an infant treated with integrase inhibitor from the neonatal period 42
Viremia copy-years and risk of estimated glomerular filtration rate reduction in adults living with perinatal HIV infection 42
Darunavir e incremento del peso corporeo: due diversi booster, stessi risultati 39
HBcAb Positivity Increases the Risk of Severe Hepatic Fibrosis Development in HIV/HCV-Positive Subjects From the ICONA Italian Cohort of HIV-Infected Patients 39
Duration of isolation and precautions in immunocompromised patients with COVID-19 37
Early administration of bamlanivimab in combination with etesevimab increases the benefits of covid-19 treatment: Real-world experience from the liguria region 37
Real-World Analysis of Survival and Clinical Events in a Cohort of Italian Perinatally HIV-1 Infected Children From 2001 to 2018 37
High doses of hydroxychloroquine do not affect viral clearance in patients with SARS-CoV-2 infection 36
Higher mortality and intensive care unit admissions in COVID-19 patients with liver enzyme elevations 35
Injectable Antiretroviral Drugs: Back to the Future 35
Role of raltegravir in patients co-infected with HIV and HCV in the era of direct antiviral agents 34
COVID-19: Some clinical questions after the first 4 months 34
Is a step-down antiretroviral therapy necessary to fight severe acute respiratory syndrome coronavirus 2 in HIV-infected patients? 30
Functional tricuspid regurgitation: The increasing clinical importance of the "forgotten valve" 29
Kidney disease and all-cause mortality in patients with COVID-19 hospitalized in Genoa, Northern Italy 26
The switch from tenofovir disoproxil fumarate to tenofovir alafenamide determines weight gain in patients on rilpivirine-based regimen 26
Integrase Inhibitors Use and Cytomegalovirus Infection Predict Immune Recovery in People Living With HIV Starting First-Line Therapy 26
Missed opportunities in tb clinical practice: How to bend the curve? A medical, social, economic and ethical point of view 25
Viremia copy-years and risk of estimated glomerular filtration rate reduction in adults living with perinatal HIV infection 25
Aspergillus-PCR in bronchoalveolar lavage - diagnostic accuracy for invasive pulmonary aspergillosis in critically ill patients 23
Totale 7.544
Categoria #
all - tutte 27.192
article - articoli 26.390
book - libri 0
conference - conferenze 498
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 80
Totale 54.160


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019265 0 0 0 0 0 0 0 0 4 52 106 103
2019/20202.185 159 54 37 137 192 233 342 207 231 326 196 71
2020/20211.332 50 137 253 109 84 84 75 120 73 130 65 152
2021/20221.201 48 39 59 138 51 98 57 270 105 126 50 160
2022/20231.562 120 117 11 132 180 197 64 185 224 118 180 34
2023/2024682 40 99 27 114 78 146 72 64 42 0 0 0
Totale 7.922